Cellectis S.A. (CLLS)
NASDAQ·Healthcare·Biotechnology
$1.12
+6.19%
Mkt Cap $361.10M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$9.00
Range $9.00 – $9.00
Implied Upside
+707.2%
Consensus $9.00 vs current $1.12
NASDAQ·Healthcare·Biotechnology
$1.12
+6.19%
Mkt Cap $361.10M
No recent rating data.
Price Target (3 analysts)
$9.00
Range $9.00 – $9.00
+707.2%
Consensus $9.00 vs current $1.12